ResearcherUniversity of BernActive in the last 2 years
Georgia Konstantinidou
Matched on ORCID iD 0000-0001-9513-0286; OpenAlex author ID A5060245726. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 7
2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 2 papers
Papers 5
- Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion. Last author DOI 10.1016/j.celrep.2026.117188↗
- Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion. Last author DOI 10.1016/j.celrep.2026.117453↗
- Restriction of extracellular lipids renders pancreatic cancer dependent on autophagy. Last author DOI 10.1186/s13046-021-02231-y↗
- Targeted Therapies for Pancreatic Cancer: Overview of Current Treatments and New Opportunities for Personalized Oncology. First author DOI 10.3390/cancers13040799↗
- ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression. Last author DOI 10.1126/sciadv.abb9200↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Matteo Rossi Sebastiano · 4 shared papers, 2020–2026 · strength 0.78
- Paper Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion. DOI 10.1016/j.celrep.2026.117188↗
- Paper Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasion. DOI 10.1016/j.celrep.2026.117453↗
- Paper Restriction of extracellular lipids renders pancreatic cancer dependent on autophagy. DOI 10.1186/s13046-021-02231-y↗
- Maciej Garczyk · 2 shared papers, 2026 · strength 0.47
- Martin Wartenberg · 2 shared papers, 2026 · strength 0.47
- Beat Gloor · 2 shared papers, 2026 · strength 0.47
- Maria Saliakoura · 2 shared papers, 2020–2022 · strength 0.31
- Cédric Leroux · 1 shared paper, 2021 · strength 0.28
- Eva Karamitopoulou · 1 shared paper, 2020 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.